ST
Stoke Ther
STOK·NASDAQBedford MAFounded 2014150 employees
Small CapbiotechPublicRare DiseaseNeurology
Platform: TANGO ASO
Market Cap
$1.2B
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (STOK)
Loading STOK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Surarelsin | STO-3092 | Phase 3 | 2 | CGRP | Cervical Ca | ||
| STO-2663 | STO-2663 | Approved | 3 | LAG-3 | CholangiocarcinomaPTSD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)